Santhera Pharmaceuticals Investor Relations Material
Latest events
H2 2024
Santhera Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Santhera Pharmaceuticals Holding Ltd
Access all reports
Santhera Pharmaceuticals Holding Ltd is a biopharmaceutical company focused on developing treatments for neuromuscular and rare diseases. The company specializes in innovative therapies targeting genetic and mitochondrial disorders, aiming to address conditions with high unmet medical needs. Its research and development efforts include advancing novel drug candidates through clinical trials and regulatory approvals. The company is headquartered in Pratteln, Switzerland, and its shares are listed on the SIX Swiss Exchange.
Key slides for Santhera Pharmaceuticals Holding Ltd
H2 2024
Santhera Pharmaceuticals Holding Ltd
H2 2024
Santhera Pharmaceuticals Holding Ltd
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
SANN
Country
🇨🇭 Switzerland